These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3602433)

  • 1. Dosimetry in interstitial curietherapy: comments on the Manchester and Paris systems as an introduction to a new system of dosimetry.
    Avanzo RC; Chierego G; Marchetti C; Pizzi G; Pozza F
    Rays; 1986; 11(1):141-6. PubMed ID: 3602433
    [No Abstract]   [Full Text] [Related]  

  • 2. Dosimetry of interstitial HDR afterloading therapy.
    Teusch P
    Sonderb Strahlenther Onkol; 1988; 82():263-5. PubMed ID: 3393998
    [No Abstract]   [Full Text] [Related]  

  • 3. The application of dose-volume histograms to the Paris and Manchester systems of brachytherapy dosimetry.
    Langmack KA; Thomas SJ
    Br J Radiol; 1995 Jan; 68(805):42-8. PubMed ID: 7881882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New 125I dosimetry in prostatic brachytherapy planning.
    Piermattei A
    Rays; 1993; 18(1):58-62. PubMed ID: 8356241
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of three brachytherapy gynecological intercavitary treatment planning systems.
    Concannon PJ; Mermis N; Nguyen L; Palmer MB
    Med Dosim; 2004; 29(2):115-7. PubMed ID: 15191758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comments on "Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43" [Med. Phys. 22, 209-234 (1995)].
    Jones D; Washington JT; Christopherson DA
    Med Phys; 1995 Aug; 22(8):1349, 1351. PubMed ID: 7476725
    [No Abstract]   [Full Text] [Related]  

  • 7. Innovative technologies in radiation therapy: brachytherapy.
    Hoskin PJ; Bownes P
    Semin Radiat Oncol; 2006 Oct; 16(4):209-17. PubMed ID: 17010903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system.
    Lehmann J; Hartmann Siantar C; Wessol DE; Wemple CA; Nigg D; Cogliati J; Daly T; Descalle MA; Flickinger T; Pletcher D; Denardo G
    Phys Med Biol; 2005 Mar; 50(5):947-58. PubMed ID: 15798267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-ultrasound fusion prostate brachytherapy: a dynamic dosimetry feedback and improvement method. A report of 54 consecutive cases.
    Fuller DB; Jin H; Koziol JA; Feng AC
    Brachytherapy; 2005; 4(3):207-16. PubMed ID: 16182221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: a Monte Carlo dose verification study.
    Pantelis E; Papagiannis P; Karaiskos P; Angelopoulos A; Anagnostopoulos G; Baltas D; Zamboglou N; Sakelliou L
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1596-602. PubMed ID: 15817368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetry of beta nuclide filled balloon catheter in endovascular brachytherapy.
    Chen Y; Geng J; Tian J; Yin D; Chen S
    Biomed Mater Eng; 2004; 14(3):337-9. PubMed ID: 15299246
    [No Abstract]   [Full Text] [Related]  

  • 12. Computed axial tomography tandem and ovoids (CATTO) dosimetry: three-dimensional assessment of bladder and rectal doses.
    Gebara WJ; Weeks KJ; Hahn CA; Montana GS; Anscher MS
    Radiat Oncol Investig; 1998; 6(6):268-75. PubMed ID: 9885943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In regard to Anagnostopoulos et al.: In vivo thermoluminescence dosimetry dose verification of transperinal (192)Ir high dose rate brachytherapy using CT-based planning for the treatment of prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:1183-1191).
    Duggan L; Bucci J; Kron T
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):911; author reply 911-2. PubMed ID: 15183495
    [No Abstract]   [Full Text] [Related]  

  • 14. Three-dimensional dosimetry in brachytherapy: A MAGAT study.
    Lin MH; Huang TC; Kao MJ; Wu J; Chen CL; Wu TH
    Appl Radiat Isot; 2009; 67(7-8):1432-7. PubMed ID: 19303785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
    Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
    Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative three-dimensional dose attenuation analysis around Fletcher-Suit-Delclos due to stainless steel tube for high-dose-rate brachytherapy by Monte Carlo calculations.
    Parsai EI; Zhang Z; Feldmeier JJ
    Brachytherapy; 2009; 8(3):318-23. PubMed ID: 19217355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology.
    Potters L; Calguaru E; Thornton KB; Jackson T; Huang D
    Brachytherapy; 2003; 2(3):172-80. PubMed ID: 15062140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo dosimetry in the urethra using alanine/ESR during (192)Ir HDR brachytherapy of prostate cancer--a phantom study.
    Anton M; Wagner D; Selbach HJ; Hackel T; Hermann RM; Hess CF; Vorwerk H
    Phys Med Biol; 2009 May; 54(9):2915-31. PubMed ID: 19384000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current brachytherapy quality assurance guidance: does it meet the challenges of emerging image-guided technologies?
    Williamson JF
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S18-22. PubMed ID: 18406923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformal treatment planning for interstitial brachytherapy.
    Kovács G; Hebbinghaus D; Dennert P; Kohr P; Wilhelm R; Kimmig B
    Strahlenther Onkol; 1996 Sep; 172(9):469-74. PubMed ID: 8830809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.